TCGX Acquisition Corp. Announces Pricing of $75,000,000 Initial Public Offering
TCGX Acquisition Corp. (the “Company”) announced today that it priced its initial public offering of 7,500,000 Class A ordinary shares at a price of $10.00 per share. Unlike certain other special purpose acquisition company initial public offerings, investors in this offering will not receive warrants that would become exercisable following completion of the Company’s initial business combination. The Class A ordinary shares will be listed on The Nasdaq Capital Market (“Nasdaq”) and trade under the ticker symbol “TCGX” beginning August 5, 2026. The offering is expected to close on August 6, 2026, subject to customary closing conditions.
The Company is a special purpose acquisition company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company is sponsored by TCGX Sponsor, LLC, an affiliate of TCG Crossover Management, LLC (“TCG Crossover”). While the Company may pursue an acquisition opportunity in any business, industry, sector or geographical location, it intends to focus its search on the healthcare and healthcare-related industries, particularly in the life sciences and medical technology sectors.
